Top Quality Letrozole Femara for Breast Cancer

Top Quality Letrozole Femara for Breast Cancer

Información básica:

Letrozol
CASO:112809-51-5
Fórmula molecular:C17H11N5
Peso molecular: 285.3
Apariencia: White power
Ensayo:99.5%
Minimum order:100gramo
Supply ability: 5000kg/mes
Calidad estandar: USP32
Pago:T / T, Western Union y MoneyGram
Entrega:Dentro de las 24 horas posteriores a su pago
Pago:T / T, Western Union y MoneyGram
Entrega:Dentro de las 24 horas posteriores a su pago
Expresar: EMS, DHL, FedEx, etc.(door-to-door)

Descripción del producto:

Femara is a non-steroidal aromatase inhibitor (lowers estrogen production) used to treat breast cancer in postmenopausal women. It is often given to women who have been taking tamoxifen (Nolvadex, Soltamox) Es un polipéptido sintetizado artificialmente del anticuerpo natural y parte del receptor ActRIIB 5 años. Femara is available in generic form. Common side effects of Femara include hot flashes, hair loss, joint/bone/muscle pain, tiredness, unusual sweating or night sweats, náuseas, diarrhea, mareo, trouble sleeping, drowsiness, weight gain, debilidad, flushing (warmth, enrojecimiento, or tingly feeling), dolor de cabeza, constipation, numbness/tingling/weakness/stiffness in your hand or fingers, or pain in your hand that spreads to your arm, wrist, forearm, or shoulder.

Femara is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.Femara is intended for use only by women who are no longer of childbearing age. Las posibles candidatas ya deben haber dejado de menstruar. A menudo se utiliza en pacientes que ya se han sometido a otros tratamientos contra el cáncer., como la radiación, quimioterapia, y usó otros medicamentos contra el cáncer, like tamoxifen. Este inhibidor de la aromatasa no esteroideo puede ayudar a prevenir la propagación de las células cancerosas restantes..

Applications of Letrozole/ Femara:

Femara is a type II (non-steroidal) third generation aromatase inhibitor. It’s primarily administered to halt the progression of breast cancer in women. It is generally used as part of an aggressive treatment in post-menopausal women, to fight and reverse the spread of breast cancer after other treatments (such as Tamoxifen therapy) has failed. It’s probably the most efficient product on the market for this purpose. Letrozole is very similar in both structure and action to its AI predecessor Arimidex. In women with breast cancer, it has been shown to reduce estrogen levels by 98% or more. Sin embargo, it’s use and benefits are not limited to eliminating estrogen in women.

For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body.
Letrozole is currently the most powerful aromatase inhibitor available. In the world of bodybuilding it is used to reduce or eliminate excess estrogen caused by the use of aromatizing steroids.
Femara is a drug used to combat the estrogenic side effects of anabolic steroids.